Evotec AG share price logo

Evotec AG

NASDAQ: EVO

Small Cap

$1.53

-0.05

(-3.16%)

as on

Evotec AG Stock Performance

as on October 31, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.50
    $1.56
    downward going graph

    1.96%

    Downside

    1.96%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.33
    $4.12
    downward going graph

    13.07%

    Downside

    169.28%

    Upside

    downward going graph

Evotec AG share price movements today

Previous Close
$1.58
Open
$1.55
Volume
436.1K
Market Cap
$588.4M
Day's Low - High
$1.50 - $1.56
52 Week Low - High
$1.33 - $4.12

Evotec AG Historical Returns

1 Month Return
-7.6 %
3 Month Return
-18.13 %
1 Year Return
-61.08 %
3 Year Return
-81.03 %
5 Year Return
0 %

Evotec AG Stock Fundamentals & Key Indicators

Check Evotec AG market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$588.4M

EPS (TTM)

-0.5592

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.68

Industry PE ratio

4.68

PEG Ratio

0.03

EBITDA

-85.4M

Revenue (TTM)

719.9M

Profit Margin

10.49%

Return On Equity TTM

-26.46%

Evotec AG vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evotec AG with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$588.4MNA-2.6810.49%0.00%
Buy$42.5BNA64.6447.54%1.06%
StrongBuy$25.2B211.14%19.4086.14%0.00%
Buy$21.5B40.60%-52.0034.83%2.56%
Buy$43.8BNA20.6265.57%1.24%

Stock Returns calculator for Evotec AG Stock including INR - Dollar returns

The Evotec AG stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 10Y

Evotec AG investment value today

Current value as on today

₹40,309

Returns

-₹59,691

(-59.69%)

Returns from Evotec AG Stock

-₹62,315 (-62.32%)

Dollar Impact

₹2,624 (+2.62%)

Analyst Recommendation on Evotec AG Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Evotec AG. Average target price of $4.21

Evotec AG Share Price Target

Get share price movements and forecasts by analysts on Evotec AG.

What analysts predicted

63.66%UPSIDE

Target Price

$4.21

Current Price

$1.53

Analyzed by

1 Analysts

High

$4

Target

$4.21

Low

$4

Evotec AG target price $4.21, a slight upside of 63.66% compared to current price of $1.53. According to 1 analysts rating.

Evotec AG Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Total Revenue
170
196
208
182
184
199
171
163
159
145
Gross Profit
46
37
34
15
18
27
8
0
-1
-1
Operating Income
-36
-12
-18
-104
-26
-20
-27
-44
-56
-51
EBITDA
-8
12
6
-11
-19
-27
-3
-17
-97
-27
Interest Expense
2
3
2
2
1
2
5
2
2
3
Depreciation
22
24
24
24
25
-
25
25
24
24
Income Before Tax
-9
-29
-14
-85
-46
-29
-43
-42
-124
-48
Income Tax Expense
5
9
6
9
-7
1
0
0
0
-1
Net Income
-14
-38
-20
-94
-39
-31
-43
-43
-123
-47
Net Profit Margin
27.20%
19.27%
16.65%
8.64%
9.89%
13.61%
5.02%
-0.04%
-1.00%
-1.10%

Evotec AG Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Mar 2022
Dec 2022
Mar 2024
Mar 2025
Mar 2026
Total Revenue
257
375
446
500
618
751
781
796
757
Gross Profit
82
112
132
125
151
174
175
114
62
Operating Income
37
77
62
48
40
20
-47
-142
-135
EBITDA
35
105
86
90
316
-57
24
-80
-13
Interest Expense
1
2
7
8
9
13
11
11
13
Depreciation
20
31
48
56
70
83
92
101
95
Income Before Tax
26
71
56
25
236
-153
-80
-193
-123
Income Tax Expense
2
-12
19
19
21
21
3
2
-23
Net Income
24
84
38
6
215
-175
-83
-196
-99
Net Profit Margin
32.05%
29.84%
29.77%
25.10%
24.52%
23.16%
22.40%
14.41%
8.27%

Evotec AG Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Net Income
-14
-38
-22
-102
-39
-31
-43
-43
-123
-47
Operating Cash Flow
-7
20
-51
-56
42
-31
26
-67
-2
-110
Investing Cash Flow
39
-15
-34
-35
-25
-21
-21
-7
-14
17
Financing Cash Flow
9
43
-6
-124
-7
35
-14
-12
-19
57
Change in Cash
46
39
-101
-224
9
-21
-17
-88
-38
-42

Evotec AG Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Mar 2022
Dec 2022
Mar 2024
Mar 2025
Mar 2026
Net Income
23
84
37
6
215
-175
-83
-196
-99
Operating Cash Flow
10
156
42
44
122
205
36
18
-9
Investing Cash Flow
-269
-39
-86
-155
-243
-412
-13
-71
159
Financing Cash Flow
240
-77
211
246
398
-58
71
-161
-30
Change in Cash
-16
42
167
145
276
-284
95
-204
148

Global Institutional Holdings in Evotec AG

Check out the Institutions with significant holdings in Evotec AG.

Funds
Holdings
Fidelity Concord Street Trust
0.00%
John Hancock Investment Trust
0.00%

Evotec AG News & Key Events

  • img

    Today's Timeline - 15 October

    Thu, 06:27 PM

    -

    Evotec appoints Dr. Joanna Holbrook as Chief Scientific Officer, effective November 1, 2026, enhancing its scientific leadership.

Insights on Evotec AG

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -123.94M → -47.42M (in $), with an average increase of 161.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 85.3% return, outperforming this stock by 146.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, SANDOZ GROUP AG SPONSORED ADS Switzerland has given 115.7% return, outperforming this stock by 197.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 253.27M → 145.85M (in $), with an average decrease of 22.8% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, EVO stock has moved down by -49.2%

About Evotec AG

Evotec SE operates globally as a dedicated partner, specializing in the discovery and advancement of new pharmaceutical products for the biotechnology and pharmaceutical sectors. Its comprehensive research and development initiatives encompass a broad spectrum of medical areas, such as metabolic disorders (including diabetes and its complications), fibrosis, infectious conditions, central nervous system (CNS) diseases, oncology, pain management, inflammatory ailments, immunological dysfunctions, rare diseases, respiratory conditions, and women's health. The company maintains strategic alliances and collaborations with numerous prominent organizations, including Bayer AG, Lilly, Chinook Therapeutics, Novo Nordisk A/S, Galapagos, Pfizer Inc., CONBA Pharmaceutical Co., Ltd., Bristol Myers Squibb Company, Zhejiang JingXin Pharmaceutical Co., Ltd, Kazia Therapeutics, Apeiron Biologics, and Takeda Pharmaceuticals. Established in 1993, the company was formerly known as Evotec AG, changing its name to Evotec SE in April 2019. Its corporate headquarters are located in Hamburg, Germany.
OrganisationEvotec AG
HeadquartersEssener Bogen 7, Hamburg, HA, 22419, DE
IndustryDrug Manufacturers - Specialty & Generic
CEOChristian Wojczewski

Key Management of Evotec AG

Name

Title

Dr. David Hallet

Executive Vice President

Uwe Andag

EVP Head of Metabolic Diseases

Dr. Christian Wojczewski Ph.D.

CEO & Chairperson of the Management Board

Ms. Aurelie Dalbiez

Chief People Officer & Member of Management Board

Ms. Claire Hinshelwood

CFO & Member of Management Board

Dr. Ingrid Mller

COO & Member of Management Board

Dr. Sarah Fakih

Executive VP, Head of Global Communications & Investor Relations

Dr. Christian Dargel

EVP Global Head of Legal & Compliance

Dr. Ian M. Hunneyball

Senior Vice President of Programme Management & Clinical Operations

Ms. Christiane Honisch

SVP Head of Diagnostics

FAQs

What is Evotec AG share price today?

Evotec AG share price today is $1.53 as on at the close of the market. Evotec AG share today touched a day high of $1.56 and a low of $1.50.

What is the 52 week high and 52 week low for Evotec AG share?

Evotec AG share touched a 52 week high of $4.12 on and a 52 week low of $1.33 on . Evotec AG stock price today i.e. is closed at $1.53,which is 62.86% down from its 52 week high and 15.04% up from its 52 week low.

What is Evotec AG's market capitalisation today?

Evotec AG market capitalisation is $0.00T as on .

How to invest in Evotec AG Stock (EVO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Evotec AG on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Evotec AG Stock (EVO) from India?

Indian investors can start investing in Evotec AG (EVO) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Evotec AG stock (as per the Rupee-Dollar exchange rate as on ). Based on Evotec AG share’s latest price of $1.53 as on October 31, 2026 at 8:45 am IST, you will get 6.5359 shares of Evotec AG. Learn more about fractional shares .